Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Company") is pleased to announce that its Board of Directors has declared a quarterly cash dividend on its common shares of C$0.50 per share ...

Tourmaline Bio said Tuesday that its experimental antibody treatment demonstrated deep reductions in a measure of inflammation often tied to heart disease, although a high placebo response in the ...

Tourmaline’s 2025 forecast production range of 635,000 - 665,000 boepd remains unchanged. Production averaged 660,000 boepd in the first half of April, according to the release.

Jeff Zuckerman has returned to Tourmaline Partners after four years to take up a managing director role. He previously left the firm to take up the position of executive director within the outsourced ...

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve ...

Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Company") is pleased to announce that its Board of Directors has declared a quarterly cash dividend on its common shares of C$0.35 per common ...

The artist Tourmaline, a lifelong scholar on the life of Marsha P. Johnson, is publishing a book on the queer historical icon. Marsha: The Joy and Defiance of Marsha P. Johnson is the first full ...

Tourmaline Oil Corp., Calgary, has completed a deal to acquire liquids-rich natural gas company Crew Energy Inc., Calgary, for total consideration of about $1.4 billion (Can.) including net debt ...

Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Company") is pleased to announce that it has closed the acquisition of Crew Energy Inc. ("Crew"), pursuant to which the Company acquired all ...

Tourmaline’s acquisition of Crew Energy is expected to close in October. With the deal, the company’s 2024 production volume guidance increases to between 582,500 and 592,500 boe/d, up from a ...

Tourmaline (highest quality and lowest risk gas producer in Canada) grows long-term per-share value and pays high special dividends. Read more on TRMLF stock here.

Tourmaline Bio's current market capitalization stands at $360.33 million, reflecting investor valuation of the company in the biotechnology sector.